1 active not recruiting, 1 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
Follow ABK Biomedical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) EYE90 Microspheres Treatment - Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable | Not applicable | Active not recruiting | ABK Biomedical | 120 | 2023-09-21 | 2026-03-04 |
| Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC) Eye90 Microspheres - Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer | Not applicable | Completed | ABK Biomedical | 8 | 2021-11-02 | 2024-11-29 |
Carcinoma, Hepatocellular (2) · Liver Diseases (2) · Liver Neoplasms (2) · Colorectal Neoplasms (1)
Canada (1) · New Zealand (1) · United States (1)
Ammar Sarwar, MD (1) · Andrew Kennedy, MD (1) · Aravind Arepally, MD (1)